Le Lézard
Classified in: Health
Subjects: WOM, CFG

Advisory - Marvelon 28 birth control pills: Packages do not contain day-of-the-week stickers


OTTAWA, Sept. 11, 2018 /CNW/ -

Issue
Health Canada is informing Canadians that packages of certain lots of Marvelon 28 do not include day-of-the-week stickers. The stickers are meant to be applied on the blister pack containing the pills. The stickers indicate the first day of the week when the medication is started, and the weekdays that the pills should be taken. The stickers may be used by women to help them remember if they took their daily pill on a given day. Without these stickers, there may be an increased chance of missing a dose.

This issue does not impact the safety or effectiveness of the pills. Canadians should continue to take their medication as prescribed. It is important to keep track of when you take your pills to avoid missing any doses.

Merck Canada Inc., the importer of Marvelon 28, is currently working to correct this issue. Merck Canada Inc. will distribute day-of-the-week stickers to pharmacies, beginning the week of September 10. Customers who use Marvelon 28 will be able to pick up the day-of-the-week stickers at no additional cost.

Who is affected

Affected products

 

Product Name 

DIN

Lot Number

Expiry

Marvelon 28

Birth control pills

02042479

R000269

R014281

N032638

R006559

R000270

N023314

March 31, 2020

March 31, 2021

March 31, 2020

March 31, 2020

March 31, 2020

October 31, 2019

 

There is no need to return Marvelon 28 products that you currently have, since this issue does not impact the efficacy or safety of the tablet itself if taken as prescribed. Note that Marvelon 21 is not affected by this situation.

What consumers should do

What Health Canada is doing
Health Canada continues to follow up with Merck Canada Inc. to make sure that appropriate measures are taken to correct the issue.

Background
Health Canada has confirmed with Merck Canada Inc. that the day-of-the-week stickers must be present in all packages of Marvelon 28.

Merck Canada Inc. has issued a letter to health care professionals to advise them of the issue and to ask them to proactively advise patients when prescribing or dispensing the product. The company will issue the day-of-week stickers to retail pharmacies starting the week of September 10, and to clinics that received samples starting the week of September 17, to include with any product already distributed.

Related links

For more information

Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: